Researchers investigated a novel SLAMF7-promoter driven oncolytic adenovirus as a potential therapeutic for multiple myeloma, an incurable hematological malignancy.
[Leukemia]
An Oncolytic Adenovirus Targeting SLAMF7 Demonstrates Anti-Myeloma Efficacy
